Prestige Consumer Healthcare Inc. reported $1.09bn in revenues for its fiscal year 2022, up 15.2%, as its fourth-quarter income jumped more than 45% despite the inflationary pressures as it avoided supply chain and shipping bottlenecks hitting many other consumer health product companies.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?